Biopsy Punches Market: Introduction

Biopsy punch is the technique to remove the round core from the center of a specified area of skin. Skin punch biopsy is necessary to diagnose Kaposi’s sarcoma and other skin lesions of unknown etiology.Biopsy punches perform skin biopsies at various locations, besides the skin on the face or hands, with great precision and minimal tissue trauma. Biopsy technique is used to diagnose accurate results, which  include bullous diseases, vasculitis, panniculitis, systemic diseases, such as lupu erythematosus (LE), dermatomyositis(DM), drug reactions, Stevense-Johnson syndrome(SJS), toxic epidermal necrolysis (TEN), staphylococcal scalded skin syndrome (SSSS), hair disorders, and neoplastic disorders. Improper samples and techniques cause limitations in the interpretation of patterns and pigmented lesions of nonmelanoma skin cancer.

Get a Glimpse of the In-depth Analysis through our Biopsy Punches Market Report Brochure

Key Drivers of Global Biopsy Punches Market

Technological advancements in medical devices

  • Medical technologies such as minimally-invasive surgeries, better monitoring systems, and more comfortable scanning equipment cause patients to spend less time in recovery
  • Adoption of technology in medical equipment and telehealth has also lead to automation in surgeries, where in some cases, physicians do not even need to be present in the operating room with a patient when the surgery is performed
  • Consistent evolution of technology that is being applied in healthcare has led to the enactment of rules and regulations concerning its use, which enable the adoption of new methods of administering care

Rapidly rising incidences of cancer and skin disorders

  • The incidence rate of melanoma is increasing worldwide, while the associated mortality remains stable, or is declining marginally
  • Skin cancer represents a highly common group of malignant neoplasms in the Caucasian population.

Demand for less invasive surgeries

  • Minimal invasive surgeries have changed the entire surgical scenario and have impacted the surgical community significantly
  • The popularity of the minimal invasive surgeries is not limited to being the alternative of invasive therapies, as it also involves short procedure time, less pain, shorter length of hospital stay, rapid recovery, and less blood loss during treatment

Product Recall Biopsy Punches

  • Product recalls by the Food and Drug Administration are likely to hamper the global biopsy punches market. For instance, On March 18, 2013, HealthLink BIOPSY PUNCHES offered by Clorox Healthcare Holdings, LLC were recalled. The reason for the recall was a lack of sterilization.
  • On November 17, 2014, PKG, 3MM INSERT, BIOPSY PUNCH, 29CM, P/N 0250282060 offered by Stryker Endoscopy was recalled. The reason for recall was that the parameters provided in the Laparoscopic Manual Instruments Instructions for Use (IFU 1000-401-070 Revision G or prior) do not support the unwrapped gravity cycle and the ethylene oxide cycle sterilization methods.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Biopsy Punches Market Report

North America to Hold Major Share of Global Biopsy Punches Market

  • North America is expected to hold a major share of the global biopsy punches market. The biopsy punches market in North America is estimated to expand at a rapid pace primarily due to technological advancements in medical devices, rapid rise in incidences of cancer and skin disorders, and demand for less invasive surgeries in the region.
  • The biopsy punches market in Asia Pacific is projected to expand at a rapid pace during the forecast period due to preference for minimally invasive procedures in the region

Key Players Operating in Global Market

The global biopsy punches market is highly concentrated due to the presence of key players. A large number of manufacturers hold a major share in their respective region. The demand for biopsy punches has increased in emerging as well as developed markets. Industry players are adopting practices of appointing third-party distributors to expand their market presence. This has led to a surge in the number of distributors and suppliers in emerging markets. Leading players operating in the global biopsy punches market include:

  • BD
  • Acuderm Inc.
  • Kai Industries Co., Ltd.
  • MEDGYN PRODUCTS, INC.
  • Integra LifeSciences Corporation
  • Sklar Surgical Instruments
  • CooperSurgical, Inc.
  • Cadence Inc.

Global Biopsy Punches Market: Research Scope

Global Biopsy Punches Market, by Type

  • Reusable Biopsy Punch
  • Disposable Biopsy Punch       

Global Biopsy Punches Market, by Application

  • Dermatology
  • Cosmetic procedures
  • Laboratories
  • Others

Global Biopsy Punches Market, by End-user

  • Hospitals & Clinics
  • Home Settings
  • Others

Global Biopsy Punches Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Biopsy Punches Market

Pre Book